This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Retinal changes prior to hydroxychloroquine toxicity

Retinal changes prior to hydroxychloroquine toxicity
Reviewed by Ed Rule

1 October 2021 | Ed Rule | EYE - Vitreo-Retinal | Ganglion cell layer, Hydroxychloroquine, Optical coherence tomography, Retina, Retinal thickness
Share This

In this retrospective longitudinal study, the authors examined changes in retinal layer thickness in patients taking hydroxychloroquine without evidence of retinopathy. Patients were drawn from a hydroxychloroquine screening clinic and required at least two OCT scans, at least one year apart. In total, 144 eyes of 144 patients were studied over an average of 38 months. The mean daily dose of hydroxychloroquine was 4.89mg/kg. Study patients had been on treatment for an average of four years. Changes in retinal thickness between the first and second OCT scan were determined using automated analysis. The authors found a small (2.2µm), but statistically significant, decrease in the thickness of the inner retinal layers at the fovea (in particular the ganglion cell layer). This finding concurs with some previous studies, though others have not detected a change in retinal thickness before overt toxicity occurs. However, the study is limited by a lack of a control group and its retrospective design.

Longitudinal retinal changes induced by hydroxychloroquine in eyes without retinal toxicity.
OPHTHALMIC RESEARCH
Godinho G, Madeira C, Falcão M, et al.
2021;64(2):290-6.
Share This
CONTRIBUTOR
Ed Rule

Wrexham Hospital, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
Related Journal Review >
  • Can coenzyme Q10 have a protective role in ethambutol-induced retinal ganglion cell toxicity
  • Bitemporal hemianopsia as a result of ethambutol toxicity

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency